Impact of tumour motion compensation and delineation methods on FDG PET-based dose painting plan quality for NSCLC radiation therapy.

about

Impact of tumour motion compensation and delineation methods on FDG PET-based dose painting plan quality for NSCLC radiation therapy.

Item

http://www.wikidata.org/entity/Q47591667

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Impact of tumour motion compen ...... y for NSCLC radiation therapy.

@en

Impact of tumour motion compen ...... y for NSCLC radiation therapy.

@nl

type

Item

label

Impact of tumour motion compen ...... y for NSCLC radiation therapy.

@en

Impact of tumour motion compen ...... y for NSCLC radiation therapy.

@nl

prefLabel

Impact of tumour motion compen ...... y for NSCLC radiation therapy.

@en

Impact of tumour motion compen ...... y for NSCLC radiation therapy.

@nl

P1476

Impact of tumour motion compen ...... ty for NSCLC radiation therapy

@en

P2093

James Jebaseelan E Samuel

http://www.w3.org/2001/XMLSchema#string

Stephen R Bowen

http://www.w3.org/2001/XMLSchema#string

P2860

A review on segmentation of positron emission tomography images

4D PET/CT as a Strategy to Reduce Respiratory Motion Artifacts in FDG-PET/CT

A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117

Quiescent period respiratory gating for PET/CT.

Feasibility and sensitivity study of helical tomotherapy for dose painting plans.

Geographic miss of lung tumours due to respiratory motion: a comparison of 3D vs 4D PET/CT defined target volumes.

Generating lung tumor internal target volumes from 4D-PET maximum intensity projections.

Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing.

PET/CT imaging artifacts.

Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgery.

P304

81-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1754-9485.12693

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul E. Kinahan

Hannah Mary Thomas

P577

2017-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29193781

http://www.w3.org/2001/XMLSchema#string

P932

5810941

http://www.w3.org/2001/XMLSchema#string